Dilip Shanghvi Resigns As MD Of SPARC

Prior to joining SPARC, Raghavan served as the managing director of the India and Sri Lanka business of Quintiles, a global pharmaceutical services company.

Sun Pharma, Officials Including Dilip Shanghvi Settle Case Of Alleged Market Norms Violation With SEBI

Sebi had received two whistleblower complaints, wherein allegations were made against Sun Pharmaceutical Industries Ltd (SPIL) and its wholly-owned subsidiary Sun Pharmaceutical Laboratories Ltd (SPLL), alleging that the firms had been diverting funds through its sole distributor in India, Aditya Medisales Ltd.

Dilip Shanghvi: Creating Milestones All The Way

Finding new growth areas and profitable markets is an ongoing quest for Sun Pharma’s Dilip Shanghvi

The Fight Is On

Sun Pharma’s Dilip Shanghvi is all set to conquer the new normal

Mukesh Ambani's Wealth At $22.7 Billion Equals Estonia's GDP: Forbes

Industrialist Mukesh Ambani, who has been named India's richest person for the 9th year in a row with a sharp increase in networth to $22.7 billion, has fortune that is equal to Estonia's GDP

Mukesh Ambani India's Richest For 9th Year, Dilip Shanghvi At 2nd Spot

Industrialist Mukesh Ambani was on Thursday named India's richest person for a ninth year in a row with a sharp increase in net worth to $22.7 billion, while Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of $16.9 billion

Sun Pharma Q4 Net Up 93 Per Cent On Exclusivity Sales In US, Low cost

Sun Pharma’s formulation sales in the United States at $580 million during the quarter grew 19 per cent over the last year

Sun Pharma: Acquiring Growth

Sun Pharma, promoted and led by the astute billionaire, Dilip Shanghvi, has always followed an inorganic growth strategy both in India and abroad.

Mukesh Ambani Is 36th Richest Man In World

Ambani leads a pack of 84 billionaires from India, with pharma magnate Dilip Shanghvi ranking 44, Wipro Chairman Azim Premji at number 55 and HCL co-founder Shiv Nadar at 88th position

Sun Pharma: Strong Biz Acumen

Shanghvi’s “patient approach” in fighting the odds helped Sun Pharma to scale up to the current level

US FDA Warns Sun Pharma Over Standards At Halol Plant

The Halol plant makes up about 15 percent of Sun Pharma's sales in its largest market, the United States. It is critical to the company as it has the capabilities to manufacture injectable products

Sun Pharma Q2 Net Profit Falls On Lower Sales

Sun Pharma Profit Down 30 Per Cent Over Compliance Costs, Lower Sales

Flipkart Founders Join List Of 100 Richest Indians

RBI To Grant Small Finance Bank Licences Next Month